Agevisa/PB Takes Action to Combat Smoking in Paraiba Region

Sep.01.2022
Agevisa/PB Takes Action to Combat Smoking in Paraiba Region
Brazil's Agevisa reinforces actions against smoking in Paraíba and emphasizes partnerships for health protection and environmental sustainability.

The Brazilian National Health Surveillance Agency (Agevisa) has been strengthening its actions and partnerships aimed at combating smoking in the Paraiba region throughout the year. On August 29th (National Day to Combat Tobacco), General Director Geraldo Moreira de Menezes outlined measures that not only aim to educate the public about the serious harm caused by tobacco products but also to train collaborating organizations to better protect human health and the state's environment.


He emphasized the importance of establishing partnerships between the State Health Surveillance Agency, Procon/PB, the Public Department, state and federal police, Sudema/PB, the Federal Revenue Service, and other state health agencies (members of this structure). This Agency has been providing advice on the implementation and execution of a quality management system for Agevisa/PB, which has yielded very positive results. The improvement of this Agency's activities in promoting and protecting human health in Paraíba has been positively impacted.


From August 22 to 25, Agevisa/PB actively participated in a training program on tobacco control legislation and inspection for health supervisors and Procons professionals in Paraiba. The event was held online and was co-organized by the National Cancer Institute (Inca), the National Health Surveillance Agency (Anvisa), and the Pan American Health Organization (PAHO).


Helena Teixeira de Lima Barbosa, the Technical Director of Agevisa/PB's Medical Science and Technology and Related department, discussed the role of health monitoring in tobacco control. She focused on the responsibilities and challenges facing regulators and highlighted the importance of societal awareness and participation in the fight against smoking. In her speech, Helena discussed Paraiba's health surveillance actions, responsibilities, legal documents, and experiences in combating smoking. She emphasized the extreme damage to health and the environment caused by the many substances in tobacco products, including electronic cigarette devices, also known as e-cigarettes.


According to Geraldo Moreira, this year Agevisa/PB has also promoted tobacco product inspection training for coordinators and municipal health inspectors to expand and improve the promotion and protection of public health in the region.


On June 14th and 15th, training was held for public health surveillance professionals in National Health Zones 1, 12, and 14. On March 30th, a training session was conducted for Visas staff from various cities in the second health zone during an event in Guarabira/PB.


Sustainability and tobacco control - Agevisa/PB is also actively involved in the National Cancer Institute's technical visit program to Paraiba to introduce sustainable tobacco control projects. From June 27th to July 1st, 2022, representatives from INCA, PAHO, the Secretary of State, and the Municipal Health Secretary discussed the project, Agevisa/PB, Empresa Paraibana de Turismo (PBTur), and tourism in the capital of Paraiba at the Casa de Jose Americo Foundation in João Pessoa/PB.


Geraldo Moreira de Menezes, the director general of Agevisa/PB, attended the event and emphasized the state government's commitment to expanding efforts to combat smoking in Paraiba. He discussed the agency's responsibility for oversight and education, and pointed out their concerns about the growth of smoking, including hookah and e-cigarettes.


Confiscation of electronic cigarettes - as part of a permanent effort to combat smoking in Paraiba, the director of Agevisa/PB emphasized on the 29th that the working group, which was launched on June 30th in João Pessoa/PB, seized a large number of electronic smoking devices at a tobacco store near Tambau. The owner of the establishment was arrested at the time and taken to the Federal Police Headquarters for questioning.


Késsia Liliana, the head of Procon/PB, Hugo José de Barros Franca, the health technology director, and Ado Augusto Bezerra de Brito, the health risk inspection and control technology manager from Agevisa attended this operation. PB, Procon inspectors, and federal police agent Geraldo Moreira announced an intensified inspection and imposed sanitary penalties on those responsible for public or private collective-use environments allowing the use of electronic cigarettes, vaporizers, vapes, and e-cigarettes throughout the state of Paraiba. The use of cigarettes, electronic cigarettes, e-cigarettes, or any other electronic smoking device (DEF) is prohibited in environments under their responsibility.


According to Geraldo Moreira, the initiative of Law 12,351/2022 aims to strengthen Paraiba's struggle against smoking by creating a smoke-free environment for collective use, considering whether Law 1 originated from smoke.


Disclaimer: 1. The content of this article is compiled from third-party information and is only for industry exchange and learning purposes. 2. This article does not represent the views of 2FIRSTS, and 2FIRSTS is also unable to confirm the truthfulness and accuracy of the content. The compile of this article is only for industry exchange and research purposes. 3. Due to the limited compilation level, the compiled article may not express the same meaning as the original, please refer to the original article for accuracy. 4. Regarding any domestic, Hong Kong, Macao, Taiwan, and foreign expressions and positions, 2FIRSTS maintains full consistency with the Chinese government. 5. The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

U.S. Expands Illicit Vape Enforcement as ATF Brings PACT Act Powers Into Trade Fraud Task Force
U.S. Expands Illicit Vape Enforcement as ATF Brings PACT Act Powers Into Trade Fraud Task Force
The U.S. Bureau of Alcohol, Tobacco, Firearms and Explosives said on September 23 that it has joined the interagency Trade Fraud Task Force to strengthen enforcement against illegal, misdeclared and smuggled vape and tobacco products. ATF will bring its authority under the Prevent All Cigarette Trafficking Act into the task force, including registration, reporting, shipping and record-inspection requirements covering interstate sales of electronic nicotine delivery systems. ATF said the move will strengthen its ability to trace illicit products from U.S. points of entry through domestic trafficking and distribution networks.
News
Sep.28 by 2Firsts Perspectives
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds American, a BAT subsidiary, showcased four Vuse Pro flavored e-cigarette pods and its VELO nicotine pouch portfolio at NACS Show 2026. Booth staff confirmed to 2Firsts that the Vuse Pro flavors are sold in the U.S., although they have not received FDA marketing authorization. BAT outlined plans to expand Vuse retail distribution and reported that VELO held a 30.5% year-to-date volume share of the U.S. modern oral nicotine category through August 2026. The booth also featured the newly launched VELO MAX range and merchandising displays combining cigarettes, vaping products and oral nicotine brands.
EXPO
Oct.09
Product | JTI Introduces Fully Dissolvable PERLZ Nicotine Pearls in UK, Expands Range From 30-Pearl Dispensers to 10-Pearl Sachets
Product | JTI Introduces Fully Dissolvable PERLZ Nicotine Pearls in UK, Expands Range From 30-Pearl Dispensers to 10-Pearl Sachets
Japan Tobacco International (JTI) has introduced PERLZ nicotine pearls in the UK, expanding its oral nicotine portfolio beyond conventional nicotine pouches. The fully dissolvable, multi-layer pearls are placed under the tongue and come in Mint and Berry flavors at concentrations of 1mg/g and 2mg/g, equivalent to approximately 0.3mg and 0.5mg of nicotine per pearl. UK retailer Haypp published four 30-pearl dispenser listings on July 31, 2026, followed by three 10-pearl sachet products on August 17. The dispensers retail for £6.50, while the sachets cost £2.50.
product
Oct.12
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia’s withdrawal of its appeal in a landmark liquid-nicotine case has left a High Court ruling that struck down the 2023 nicotine exemption in force, bringing liquid and gel nicotine used in vaping products back under the Poisons Act 1952. At the same time, the Control of Smoking Products for Public Health Act 2024 continues to provide a regulatory framework for vaping products, creating uncertainty over retail sales, taxation and existing inventory. MPs are calling for nicotine vape sales and excise collection to stop, including refunds of more than RM354 million collected since 2023, while industry and consumer groups are asking the government to clarify the current legal position.
Sep.04
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Imperial Brands' acquisition of Swedish Helwit owner Yoik Group AB has highlighted the professional-services firms supporting cross-border oral nicotine M&A. Latham & Watkins and KPMG advised Imperial, while PwC and TM & Partners advised Yoik. KPMG also appeared on Imperial's acquisition of Black Buffalo earlier in 2026, while PwC played an extensive role in KT&G's acquisition of Swedish nicotine-pouch company Another Snus Factory. Imperial's public disclosures put the global modern oral nicotine delivery market at approximately £8.8 billion in retail sales and 23.5 billion pouches in 2024
Sep.20